Skip to Content
BiomoleculesBiomolecules
  • Review
  • Open Access

25 December 2024

32 Pages

Reactive Oxygen Species, a Potential Therapeutic Target for Vascular Dementia

,
,
,
,
and
1
Clinical Neuroscience Research Center, Department of Neurosurgery, Tulane University School of Medicine, New Orleans, LA 70112, USA
2
Tulane Brain Institute, Tulane University, New Orleans, LA 70112, USA
3
Department of Microbiology and Immunology, Tulane University School of Medicine, New Orleans, LA 70112, USA
4
Department of Neurology, Tulane University School of Medicine, New Orleans, LA 70112, USA

Abstract

Vascular dementia (VaD) is a progressive neurodegenerative condition prevalent among elderly adults marked by cognitive decline resulting from injured and/or improperly functioning cerebrovasculature with resultant disruptions in cerebral blood flow. Currently, VaD has no specific therapeutics and the exact pathobiology is still being investigated. VaD has been shown to develop when reactive oxygen species (ROS) form from damaged targets at different levels of organization—mitochondria, endothelial cells, or cerebrovasculature. In this review, we highlight how specific ROS molecules may be important in the development of VaD and how they can be targeted as a potential therapeutic for VaD.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.